Altered Mechanical Properties of Astrocytes Lacking MLC1: Implications for the Leukodystrophy MLC

Quinty Bisseling1,2, Emma M J Passchier1,2, Freya M Kirwan1

  • 1Department of Child Neurology, Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, the Netherlands.

Glia
|December 2, 2025
PubMed

Insights

Loss of the astrocyte protein MLC1 causes Megalencephalic Leukoencephalopathy with subcortical Cysts (MLC). Mlc1-null astrocytes are softer, with altered cell-matrix interactions, suggesting new therapeutic targets.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biophysics

Background:

  • Megalencephalic Leukoencephalopathy with subcortical Cysts (MLC) is a leukodystrophy caused by loss of function of the astrocyte protein MLC1.
  • MLC1 dysfunction leads to astrocyte swelling and impaired attachment to blood vessels, but its precise cellular function remains unclear.
  • Astrocyte volume regulation involves mechanosensitive ion channels and cytoskeleton-membrane interactions.

Purpose of the Study:

  • To investigate the mechanical properties of primary astrocytes lacking MLC1 (Mlc1-null).
  • To determine if MLC1 influences cytoskeleton-membrane-extracellular matrix (ECM) interactions.
  • To explore potential therapeutic strategies targeting astrocyte mechanobiology in MLC.

Main Methods:

  • Indentation technique to measure the mechanical properties of cultured primary astrocytes.
  • Proteomic analysis and western blots to assess cytoskeleton-related pathways.
  • Confocal imaging to examine cytoskeletal organization and focal adhesions.

Main Results:

  • Mlc1-null astrocytes exhibited significantly reduced stiffness compared to wild-type astrocytes.
  • Dysregulation of cytoskeleton-related pathways was confirmed in Mlc1-null astrocytes.
  • A decrease in focal adhesions was observed in Mlc1-null astrocytes, while MLC1 overexpression increased focal adhesions in HeLa cells.

Conclusions:

  • Altered mechanical properties and disrupted cytoskeleton-membrane-ECM interactions contribute to Mlc1-null astrocyte dysfunction.
  • These findings highlight the role of astrocyte mechanobiology in MLC pathogenesis.
  • Modulating astrocyte mechanobiology presents a potential therapeutic avenue for MLC.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...